A cancer molecular diagnosis is a laboratory test that examines certain genes, proteins, or other molecules in a sample of tissue, blood, or other body fluids.It also examines certain changes in genes or chromosomes that may cause or affect the chances of developing cancer.To help diagnose certain types of cancer.It can also be used to help plan treatment and find out treatment effects or prognosis.
This report contains market size and forecasts of Molecular Diagnostics Cancer in Global, including the following market information:
Global Molecular Diagnostics Cancer Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Molecular Diagnostics Cancer market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Pharmacogenomic Diagnosis Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Molecular Diagnostics Cancer include Roche, Danaher, Siemens, Abbott Laboratories, ICON Plc, AstraZeneca, MDxHealth, Invitae and PlexBio, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Molecular Diagnostics Cancer companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Molecular Diagnostics Cancer Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Molecular Diagnostics Cancer Market Segment Percentages, by Type, 2021 (%)
Pharmacogenomic Diagnosis
Liquid Biopsy
Other
Global Molecular Diagnostics Cancer Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Molecular Diagnostics Cancer Market Segment Percentages, by Application, 2021 (%)
Respiratory Cancer
Cancer of Digestive System
Cancer of Urinary System
Cancer of Circulatory System
Motor System Cancer
Reproductive System Cancer
Other
Global Molecular Diagnostics Cancer Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Molecular Diagnostics Cancer Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Molecular Diagnostics Cancer revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Molecular Diagnostics Cancer revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Danaher
Siemens
Abbott Laboratories
ICON Plc
AstraZeneca
MDxHealth
Invitae
PlexBio
Thermo Fisher Scientific
Guardant Health
Biocartis
Bio-Techne
Merck
Foundation Medicine
10X Genomics
Biodesix
CytoTrack
GenomOncology
Luminex